×
Please click
here
if you are not redirected within a few seconds.
All
News
Videos
Images
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Pharmaust Limited Announces New Director's Stake - TipRanks.com
Tipranks
Pharmaust Limited (AU:PAA) has released an update. Pharmaust Limited has disclosed the commencement of John Clark's role as a director on May 9, 2024,...
1 day ago
We Think PharmAust (ASX:PAA) Can Afford To Drive Business Growth
Yahoo Finance
We Think PharmAust (ASX:PAA) Can Afford To Drive Business Growth ... Even when a business is losing money, it's possible for shareholders to make...
1 month ago
PharmAust suffers board exodus as chairman among departures
Business News Australia
The surprise announcement by Dr Michael Thurn to resign as CEO of PharmAust (ASX: PAA) last month, less than a year into the role,...
2 days ago
FDA, company to discuss advancing monepantel in ALS clinical trials
ALS News Today
FDA, PharmAust to meet over plans for Phase 2/3 trial of monepantel · Researchers develop algorithm to predict ALS survival · Monepantel shows...
4 months ago
Pharmaust Limited Announces Director Resignation - TipRanks.com
Tipranks
Pharmaust Limited (AU:PAA) has released an update. Pharmaust Limited has announced that Dr. Roger Aston ceased his position as a director of the company on...
1 day ago
Did Business Growth Power PharmAust's (ASX:PAA) Share Price Gain of 175%?
Yahoo
PharmAust Limited (ASX:PAA) shareholders have seen the share price descend 12% over the month. But that doesn't...
3 days ago
Pivotal trial next for Pharmaust after MND/ALS phase I success
BioWorld MedTech
Pharmaust Ltd.'s monepantel met its primary safety endpoints and showed positive signals of potential efficacy in a phase I trial in...
2 months ago
PharmAust plans for pivotal Phase 2/3 trial after key quarter of milestones
Stockhead
PharmAust has made significant progression on the clinical trial front last quarter with the highlight being positive top-line results.
1 week ago
Here's Why We're Not Too Worried About PharmAust's (ASX:PAA) Cash Burn Situation
Simply Wall Street
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, PharmAust ( ASX:PAA...
1 month ago
Vet drug monepantel slows ALS, MND disease progression in trial
ALS News Today
Treatment with monepantel, a drug used in veterinary medicine, slowed ALS and MND disease progression by as much as 58% in a Phase 1 trial.
1 month ago